Clinical trials
Recruiting Phase 1/2 Biliary Tract Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
21 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2022 | 2 |
| 2023 | 3 |
| 2024 | 6 |
| 2025 | 7 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 21 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Yuhan Corporation | 2 |
| Akeso | 1 |
| Avenzo Therapeutics, Inc. | 1 |
| Beijing Biotech | 1 |
| Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. | 1 |
| Daiichi Sankyo | 1 |
| DualityBio Inc. | 1 |
| Hangzhou Hanx Biopharmaceuticals, Ltd. | 1 |
| M.D. Anderson Cancer Center | 1 |
| Marengo Therapeutics, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Biliary Tract Neoplasms | 21 |
| Colorectal Neoplasms | 7 |
| Endometrial Neoplasms | 7 |
| Carcinoma, Non-Small-Cell Lung | 6 |
| Breast Neoplasms | 5 |
| Neoplasm Metastasis | 5 |
| Ovarian Neoplasms | 5 |
| Stomach Neoplasms | 5 |
| Uterine Cervical Neoplasms | 5 |
| Carcinoma | 4 |
Trials
Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.